Back to Rankings

RPRX

RoyaltyB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
RPRX vs peer average
62/100
RPRX vs. peer average (B vs. C)
Grade spread
A 1 · B 3 · C 2 · D 1 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

NTRA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $30.47B

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerNTRANatera
RPRX
Royalty
NTRA
Natera
Grade
B
C
Momentum
80
45
Value
61
48
Sentiment
37
62
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs NTRA

RPRX / NTRA
Grade Position
In line
RPRX vs. peer average (B vs. C)
62/100
Momentum
80
RPRX
Value
61
RPRX
Sentiment
37
NTRA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RPRX
1
NTRA
Natera Inc Common
C
60/100
+1
2
ZTS
Zoetis Inc Class A Common
F
20/100
+3
3
ONC
BeOne Medicines Ltd ADR
D
40/100
+2
4
IQV
IQVIA Holdings Inc Common
C
60/100
+1
5
RVMD
Revolution Medicines Inc Common
B
80/100
Even
NTRA is the first peer returned for this comparison set.